Can a drug duo tame a rare eye cancer that has spread?
Disease control
Terminated
This trial is testing whether combining two drugs—pembrolizumab and lenvatinib—can help people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. Participants receive both drugs for up to two years. The study measures how long people liv…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC